Artículos de revistas sobre el tema "Cerebral ischemia – Treatment"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Cerebral ischemia – Treatment".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Kanazawa, Masato, Tetsuya Takahashi, Masanori Ishikawa, Osamu Onodera, Takayoshi Shimohata y Gregory J. del Zoppo. "Angiogenesis in the ischemic core: A potential treatment target?" Journal of Cerebral Blood Flow & Metabolism 39, n.º 5 (6 de marzo de 2019): 753–69. http://dx.doi.org/10.1177/0271678x19834158.
Texto completoSiesjö, Bo K. "Pathophysiology and treatment of focal cerebral ischemia". Journal of Neurosurgery 77, n.º 3 (septiembre de 1992): 337–54. http://dx.doi.org/10.3171/jns.1992.77.3.0337.
Texto completoWang, Lei, Xu Zhang, Xiaoxing Xiong, Hua Zhu, Ran Chen, Shudi Zhang, Gang Chen y Zhihong Jian. "Nrf2 Regulates Oxidative Stress and Its Role in Cerebral Ischemic Stroke". Antioxidants 11, n.º 12 (30 de noviembre de 2022): 2377. http://dx.doi.org/10.3390/antiox11122377.
Texto completoSiesjö, Bo K. "Pathophysiology and treatment of focal cerebral ischemia". Journal of Neurosurgery 108, n.º 3 (marzo de 2008): 616–31. http://dx.doi.org/10.3171/jns/2008/108/3/0616.
Texto completoSiesjö, Bo K. "Pathophysiology and treatment of focal cerebral ischemia". Journal of Neurosurgery 77, n.º 2 (agosto de 1992): 169–84. http://dx.doi.org/10.3171/jns.1992.77.2.0169.
Texto completoHan, Xue Mei, Hong Tao Wei y Song Yan Liu. "Involvement of Erythropoietin Expression in Acupuncture Preconditioning-Induced Ischemic Tolerance". Advanced Materials Research 554-556 (julio de 2012): 1650–55. http://dx.doi.org/10.4028/www.scientific.net/amr.554-556.1650.
Texto completoSong, Siying, Hao Wu, Xunming Ji y Ran Meng. "The BE COOL Treatments (Batroxobin, oxygEn, Conditioning, and cOOLing): Emerging Adjunct Therapies for Ischemic Cerebrovascular Disease". Journal of Clinical Medicine 11, n.º 20 (20 de octubre de 2022): 6193. http://dx.doi.org/10.3390/jcm11206193.
Texto completoSpetzler, Robert F. "Treatment of chronic cerebral ischemia". Surgical Neurology 23, n.º 2 (febrero de 1985): 201. http://dx.doi.org/10.1016/0090-3019(85)90350-7.
Texto completoGhosh, Nilanjan, Rituparna Ghosh, Zulfiqar A. Bhat, Vivekananda Mandal, Sitesh C. Bachar, Namsa D. Nima, Otimenyin O. Sunday y Subhash C. Mandal. "Advances in Herbal Medicine for Treatment of Ischemic Brain Injury". Natural Product Communications 9, n.º 7 (julio de 2014): 1934578X1400900. http://dx.doi.org/10.1177/1934578x1400900739.
Texto completoHan, Xue Mei, Hong Tao Wei y Song Yan Liu. "Functional Role of HIF-1α in Hypoxic Preconditioning-Induced Neuroprotection against Focal Cerebral Ischemia". Advanced Materials Research 554-556 (julio de 2012): 1762–67. http://dx.doi.org/10.4028/www.scientific.net/amr.554-556.1762.
Texto completoDong, Chao, Jiawei Li, Ming Zhao, Lin Chen, Xiaochen Zhai, Lingling Song, Jin Zhao, Qiang Sun, Jie Wu y Xiaolu Xie. "Pharmacological Effect of Panax notoginseng Saponins on Cerebral Ischemia in Animal Models". BioMed Research International 2022 (4 de agosto de 2022): 1–12. http://dx.doi.org/10.1155/2022/4281483.
Texto completoYe, Hui, Zaiming Liu, Long Zhou y Qiang Cai. "Dynamic Observation of the Effect of L-Theanine on Cerebral Ischemia-Reperfusion Injury Using Magnetic Resonance Imaging under Mathematical Model Analysis". Journal of Healthcare Engineering 2021 (26 de octubre de 2021): 1–7. http://dx.doi.org/10.1155/2021/5679665.
Texto completoLopez, Mary S., Robert J. Dempsey y Raghu Vemuganti. "Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles". Journal of Cerebral Blood Flow & Metabolism 36, n.º 9 (21 de julio de 2016): 1644–50. http://dx.doi.org/10.1177/0271678x16656202.
Texto completoLi, Jin-hui, Jing Lu y Hong Zhang. "Functional Recovery after Scutellarin Treatment in Transient Cerebral Ischemic Rats: A Pilot Study with18F-Fluorodeoxyglucose MicroPET". Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/507091.
Texto completoYano, Toshiyuki, Sakiko Anraku, Ryosuke Nakayama y Kazuo Ushijima. "Neuroprotective Effect of Urinary Trypsin Inhibitor against Focal Cerebral Ischemia–Reperfusion Injury in Rats". Anesthesiology 98, n.º 2 (1 de febrero de 2003): 465–73. http://dx.doi.org/10.1097/00000542-200302000-00028.
Texto completoYagita, Yoshiki, Kazuo Kitagawa, Naoki Oyama, Toshiro Yukami, Akihiro Watanabe, Tsutomu Sasaki y Hideki Mochizuki. "Functional Deterioration of Endothelial Nitric Oxide Synthase after Focal Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 33, n.º 10 (3 de julio de 2013): 1532–39. http://dx.doi.org/10.1038/jcbfm.2013.112.
Texto completoPikis, Stylianos, Georgios Mantziaris, Vasileios Mamalis, Konstantinos Barkas, Antonios Tsanis, Stavroula Lyra, Kuriakos Karkoulias, Tigran Petrosyan y Eftychios Archontakis. "Diffusion weighted image documented cerebral ischemia in the postprocedural period following pipeline embolization device with shield technology treatment of unruptured intracranial aneurysms: a prospective, single center study". Journal of NeuroInterventional Surgery 12, n.º 4 (26 de septiembre de 2019): 407–11. http://dx.doi.org/10.1136/neurintsurg-2019-015363.
Texto completoYu, Yong-Qiang, Lian-Cheng Liu, Fa-Cai Wang, Yan Liang, Da-Qin Cha, Jing-Jing Zhang, Yu-Jun Shen, Hai-Ping Wang, Shengyun Fang y Yu-Xian Shen. "Induction Profile of MANF/ARMET by Cerebral Ischemia and its Implication for Neuron Protection". Journal of Cerebral Blood Flow & Metabolism 30, n.º 1 (23 de septiembre de 2009): 79–91. http://dx.doi.org/10.1038/jcbfm.2009.181.
Texto completoSavić, Tanja, Giuseppe Gambino, Vahid S. Bokharaie, Hamid R. Noori, Nikos K. Logothetis y Goran Angelovski. "Early detection and monitoring of cerebral ischemia using calcium-responsive MRI probes". Proceedings of the National Academy of Sciences 116, n.º 41 (23 de septiembre de 2019): 20666–71. http://dx.doi.org/10.1073/pnas.1908503116.
Texto completoAhad, Mohamad Anuar, Kesevan Rajah Kumaran, Tiang Ning, Nur Izzati Mansor, Mohamad Azmeer Effendy, Thenmoly Damodaran, Kamilla Lingam et al. "Insights into the neuropathology of cerebral ischemia and its mechanisms". Reviews in the Neurosciences 31, n.º 5 (28 de julio de 2020): 521–38. http://dx.doi.org/10.1515/revneuro-2019-0099.
Texto completoJacewicz, Michael, Steve Brint, Jody Tanabe, Xing-Je Wang y William A. Pulsinelli. "Nimodipine Pretreatment Improves Cerebral Blood Flow and Reduces Brain Edema in Conscious Rats Subjected to Focal Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 10, n.º 6 (noviembre de 1990): 903–13. http://dx.doi.org/10.1038/jcbfm.1990.147.
Texto completoJacewicz, Michael, Steve Brint, Jody Tanabe y William A. Pulsinelli. "Continuous Nimodipine Treatment Attenuates Cortical Infarction in Rats Subjected to 24 Hours of Focal Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 10, n.º 1 (enero de 1990): 89–96. http://dx.doi.org/10.1038/jcbfm.1990.11.
Texto completoSun, Jui-Ming, Ting-Lin Yen, Jing-Shiun Jan, Pharaoh Fellow Mwale, Ruei-Dun Teng, Rajeev Taliyan, Cheng-Ta Hsieh y Chih-Hao Yang. "Advances in Antibody-Based Therapeutics for Cerebral Ischemia". Pharmaceutics 15, n.º 1 (31 de diciembre de 2022): 145. http://dx.doi.org/10.3390/pharmaceutics15010145.
Texto completoVongsfak, Jirapong, Wasana Pratchayasakul, Nattayaporn Apaijai, Tanat Vaniyapong, Nipon Chattipakorn y Siriporn C. Chattipakorn. "The Alterations in Mitochondrial Dynamics Following Cerebral Ischemia/Reperfusion Injury". Antioxidants 10, n.º 9 (30 de agosto de 2021): 1384. http://dx.doi.org/10.3390/antiox10091384.
Texto completoPackard, Amy E. B., Jason C. Hedges, Frances R. Bahjat, Susan L. Stevens, Michael J. Conlin, Andres M. Salazar y Mary P. Stenzel-Poore. "Poly-IC Preconditioning Protects against Cerebral and Renal Ischemia-Reperfusion Injury". Journal of Cerebral Blood Flow & Metabolism 32, n.º 2 (16 de noviembre de 2011): 242–47. http://dx.doi.org/10.1038/jcbfm.2011.160.
Texto completoSmirnov, Ivan E., A. A. Stepanov, L. D. Shakina, I. A. Belyaeva, E. P. Bombardirova y A. G. Kucherenko. "Neurologic manifestations of cerebral ischemia in infants at 1 year of age". Russian Pediatric Journal 19, n.º 5 (30 de abril de 2019): 274–82. http://dx.doi.org/10.18821/1560-9561-2016-19-5-274-282.
Texto completoZhang, Chan, Luming Zhen, Zongping Fang, Liang Yu, Yuanyuan Zhang, Haidong Wei, Junfeng Jia y Shiquan Wang. "Adiponectin Treatment Attenuates Cerebral Ischemia-Reperfusion Injury through HIF-1α-Mediated Antioxidation in Mice". Oxidative Medicine and Cellular Longevity 2021 (14 de julio de 2021): 1–16. http://dx.doi.org/10.1155/2021/5531048.
Texto completoMarteau, Léna, Samuel Valable, Didier Divoux, Simon A. Roussel, Omar Touzani, Eric T. MacKenzie, Myriam Bernaudin y Edwige Petit. "Angiopoietin-2 is Vasoprotective in the Acute Phase of Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 33, n.º 3 (5 de diciembre de 2012): 389–95. http://dx.doi.org/10.1038/jcbfm.2012.178.
Texto completoArmstrong, SL. "Cerebral vasospasm: early detection and intervention". Critical Care Nurse 14, n.º 4 (1 de agosto de 1994): 33–37. http://dx.doi.org/10.4037/ccn1994.14.4.33.
Texto completoDu, Fang, Tao Tang, Qingzhu Li y Jiaxin Liu. "Fyn Signaling in Ischemia-Reperfusion Injury: Potential and Therapeutic Implications". Mediators of Inflammation 2022 (15 de septiembre de 2022): 1–10. http://dx.doi.org/10.1155/2022/9112127.
Texto completoLim, Songhyun, Tae Jung Kim, Young-Ju Kim, Cheesue Kim, Sang-Bae Ko y Byung-Soo Kim. "Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury". International Journal of Molecular Sciences 22, n.º 21 (4 de noviembre de 2021): 11967. http://dx.doi.org/10.3390/ijms222111967.
Texto completoPu, Fengling, Kenichi Mishima, Nobuaki Egashira, Yuki Akiyoshi, An-Xin Liu, Kazunori Sano, Keiichi Irie et al. "Post-ischemic Treatment with Toki-Shakuyaku-San (Tang-Gui-Shao-Yao-San) Prevents the Impairment of Spatial Memory Induced by Repeated Cerebral Ischemia in Rats". American Journal of Chinese Medicine 33, n.º 03 (enero de 2005): 475–89. http://dx.doi.org/10.1142/s0192415x05003077.
Texto completoGodínez-Rubí, Marisol, Argelia E. Rojas-Mayorquín y Daniel Ortuño-Sahagún. "Nitric Oxide Donors as Neuroprotective Agents after an Ischemic Stroke-Related Inflammatory Reaction". Oxidative Medicine and Cellular Longevity 2013 (2013): 1–16. http://dx.doi.org/10.1155/2013/297357.
Texto completoLiang, Jia, Zhifeng Qi, Wenlan Liu, Peng Wang, Wenjuan Shi, Wen Dong, Xunming Ji, Yumin Luo y Ke Jian Liu. "Normobaric Hyperoxia Slows Blood–Brain Barrier Damage and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in Cerebral Ischemia". Stroke 46, n.º 5 (mayo de 2015): 1344–51. http://dx.doi.org/10.1161/strokeaha.114.008599.
Texto completoLu, Hongwei, Yaqin Meng, Xinrui Han y Wei Zhang. "ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury". Journal of Healthcare Engineering 2021 (16 de diciembre de 2021): 1–14. http://dx.doi.org/10.1155/2021/3097432.
Texto completoBullock, R., D. I. Graham, S. Swanson y J. McCulloch. "Neuroprotective Effect of the AMPA Receptor Antagonist LY-293558 in Focal Cerebral Ischemia in the Cat". Journal of Cerebral Blood Flow & Metabolism 14, n.º 3 (mayo de 1994): 466–71. http://dx.doi.org/10.1038/jcbfm.1994.57.
Texto completoFan, Yan-Ying, Zhe Shen, Ping He, Lei Jiang, Wei-wei Hou, Yao Shen, Xiang-Nan Zhang, Wei-Wei Hu y Zhong Chen. "A Novel Neuroprotective Strategy for Ischemic Stroke: Transient Mild Acidosis Treatment by CO2 Inhalation at Reperfusion". Journal of Cerebral Blood Flow & Metabolism 34, n.º 2 (6 de noviembre de 2013): 275–83. http://dx.doi.org/10.1038/jcbfm.2013.193.
Texto completoRegli, Luca, Mark C. Held, Robert E. Anderson y Fredric B. Meyer. "Nitric Oxide Synthase Inhibition by L-NAME Prevents Brain Acidosis during Focal Cerebral Ischemia in Rabbits". Journal of Cerebral Blood Flow & Metabolism 16, n.º 5 (septiembre de 1996): 988–95. http://dx.doi.org/10.1097/00004647-199609000-00024.
Texto completoSchulz, Mette K., Lars Peter Wang, Mogens Tange y Per Bjerre. "Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage". Journal of Neurosurgery 93, n.º 5 (noviembre de 2000): 808–14. http://dx.doi.org/10.3171/jns.2000.93.5.0808.
Texto completoSchweizer, Sophie, Andreas Meisel y Stefanie Märschenz. "Epigenetic Mechanisms in Cerebral Ischemia". Journal of Cerebral Blood Flow & Metabolism 33, n.º 9 (12 de junio de 2013): 1335–46. http://dx.doi.org/10.1038/jcbfm.2013.93.
Texto completoIwata, Naohiro, Hiroko Takayama, Meiyan Xuan, Shinya Kamiuchi, Hirokazu Matsuzaki, Mari Okazaki y Yasuhide Hibino. "Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats". BioMed Research International 2015 (2015): 1–10. http://dx.doi.org/10.1155/2015/189292.
Texto completoZakharov, V. V., V. V. Grinyuk, N. V. Vakhnina y E. Yu Kalimeeva. "Treatment of comorbid patients with chronic brain ischemia and vertebrogenic pain syndromes". Medical Council, n.º 9 (12 de junio de 2019): 15–20. http://dx.doi.org/10.21518/2079-701x-2019-9-15-20.
Texto completoISHIKAWA, Tatsuya. "Advancement in Treatment for Ischemic Cerebral Ischemia in the Acute Stage". Surgery for Cerebral Stroke 33, n.º 2 (2005): 85–88. http://dx.doi.org/10.2335/scs.33.85.
Texto completoKoerner, Ines P., Matthias Gatting, Ruediger Noppens, Oliver Kempski y Ansgar M. Brambrink. "Induction of Cerebral Ischemic Tolerance by Erythromycin Preconditioning Reprograms the Transcriptional Response to Ischemia and Suppresses Inflammation". Anesthesiology 106, n.º 3 (1 de marzo de 2007): 538–47. http://dx.doi.org/10.1097/00000542-200703000-00019.
Texto completoMeng, Wei, Xiaoying Wang, Minoru Asahi, Tsuneo Kano, Kazuko Asahi, Robert H. Ackerman y Eng H. Lo. "Effects of Tissue Type Plasminogen Activator in Embolic versus Mechanical Models of Focal Cerebral Ischemia in Rats". Journal of Cerebral Blood Flow & Metabolism 19, n.º 12 (diciembre de 1999): 1316–21. http://dx.doi.org/10.1097/00004647-199912000-00004.
Texto completoChen, Jun, Roger P. Simon, Tesuya Nagayama, Raymond Zhu, J. Eric Loeffert, Simon C. Watkins y Steven H. Graham. "Suppression of Endogenous bcl-2 Expression by Antisense Treatment Exacerbates Ischemic Neuronal Death". Journal of Cerebral Blood Flow & Metabolism 20, n.º 7 (julio de 2000): 1033–39. http://dx.doi.org/10.1097/00004647-200007000-00002.
Texto completoCaraban, B. M., Aurelia Romila, L. T. Hangan y Mihaela Lungu. "Cerebral Vasospasm in Subarachnoid Hemorrhage Through Aneurysm Rupture - Clinical Considerations and Case Report". ARS Medica Tomitana 22, n.º 4 (1 de noviembre de 2016): 232–38. http://dx.doi.org/10.1515/arsm-2016-0040.
Texto completoSharma, Shyam S., Shankar Munusamy, Meenakshisundaram Thiyagarajan y Chaman L. Kaul. "Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate—ribose) polymerase inhibitor alone and in combination in rats with focal ischemia". Journal of Neurosurgery 101, n.º 4 (octubre de 2004): 669–75. http://dx.doi.org/10.3171/jns.2004.101.4.0669.
Texto completoFedin, A. I. "Diagnosis and treatment of chronic cerebral ischemia". Consilium Medicum 18, n.º 2 (2016): 8–12. http://dx.doi.org/10.26442/2075-1753_2016.2.8-12.
Texto completoZakharov, V. V., N. V. Vakhnina, A. G. Gogoleva y S. K. Mezhmidinova. "Diagnostics and treatment of chronic cerebral ischemia". Meditsinskiy sovet = Medical Council, n.º 8 (16 de julio de 2020): 36–45. http://dx.doi.org/10.21518/2079-701x-2020-8-36-45.
Texto completo